Aurora Cannabis Inc (ACB) Stock Price and Analyst Predictions

Aurora Cannabis Inc (NASDAQ: ACB) has a price-to-earnings ratio that is above its average at 0.70x. and a 36-month beta value of 2.46. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 8 as “hold,” and 0 as “sell.”

The average price predicted for Aurora Cannabis Inc (ACB) by analysts is $0.69, which is $0.3 above the current market price. The public float for ACB is 433.14M, and at present, short sellers hold a 8.33% of that float. On November 10, 2023, the average trading volume of ACB was 21.07M shares.

ACB) stock’s latest price update

Aurora Cannabis Inc (NASDAQ: ACB)’s stock price has plunge by 5.12relation to previous closing price of 0.44. Nevertheless, the company has seen a -4.53% plunge in its stock price over the last five trading sessions. Seeking Alpha reported 2023-11-09 that Aurora Cannabis Inc. (NASDAQ:ACB ) Q2 2024 Earnings Conference Call November 9, 2023 5:00 PM ET Company Participants Ananth Krishnan – Vice President, Corporate Development and Strategy Miguel Martin – Chief Executive Officer Glen Ibbott – Chief Financial Officer Conference Call Participants Vivien Azer – TD Cowen Michael Lavery – Piper Sandler John Zamparo – CIBC Doug Miehm – RBC Capital Markets Emily Larsen – BMO Capital Markets Eric Livshits – ATB Capital Markets Operator Good day, ladies and gentlemen. And welcome to Aurora Cannabis Inc. Second Quarter 2024 Results Conference Call.

ACB’s Market Performance

Aurora Cannabis Inc (ACB) has seen a -4.53% fall in stock performance for the week, with a -6.91% decline in the past month and a -13.00% plunge in the past quarter. The volatility ratio for the week is 8.69%, and the volatility levels for the past 30 days are at 7.36% for ACB. The simple moving average for the past 20 days is 1.16% for ACB’s stock, with a -25.99% simple moving average for the past 200 days.

ACB Trading at -18.94% from the 50-Day Moving Average

After a stumble in the market that brought ACB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -71.12% of loss for the given period.

Volatility was left at 7.36%, however, over the last 30 days, the volatility rate increased by 8.69%, as shares sank -6.33% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -1.71% lower at present.

During the last 5 trading sessions, ACB fell by -3.67%, which changed the moving average for the period of 200-days by -51.34% in comparison to the 20-day moving average, which settled at $0.4609. In addition, Aurora Cannabis Inc saw -49.30% in overturn over a single year, with a tendency to cut further losses.

Stock Fundamentals for ACB

Current profitability levels for the company are sitting at:

  • -109.01 for the present operating margin
  • -27.59 for the gross margin

The net margin for Aurora Cannabis Inc stands at -113.73. The total capital return value is set at -15.99, while invested capital returns managed to touch -17.91. Equity return is now at value 56.08, with 32.61 for asset returns.

Based on Aurora Cannabis Inc (ACB), the company’s capital structure generated 46.81 points at debt to equity in total, while total debt to capital is 31.88. Total debt to assets is 24.56, with long-term debt to equity ratio resting at 16.45. Finally, the long-term debt to capital ratio is 11.21.

When we switch over and look at the enterprise to sales, we see a ratio of 0.79, with the company’s debt to enterprise value settled at 0.87. The receivables turnover for the company is 4.78 and the total asset turnover is 0.13. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.98.

Conclusion

To sum up, Aurora Cannabis Inc (ACB) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Author: CSN